"UK fails to respect NICE (National Institute for Health and Clinical Excellence) on AMD (age-related macular degeneration) access to PDT"
This article was originally published in Clinica
Executive Summary
UK delays in the diagnosis and care of wet age-related macular degeneration (AMD) are such that only a half of patients are receiving treatment within the window of opportunity that can avert irreversible eye damage or even blindness.